Insider Transactions in Q4 2024 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
Lisa Von Moltke |
SELL
Open market or private sale
|
Direct |
4,334
-12.47%
|
$0
$0.69 P/Share
|
|
Oct 28
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
4,259
-3.09%
|
$0
$0.69 P/Share
|
|
Oct 28
2024
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
3,984
-4.99%
|
$0
$0.69 P/Share
|
|
Oct 28
2024
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
2,983
-3.26%
|
$0
$0.69 P/Share
|
|
Oct 28
2024
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
8,748
-5.03%
|
$0
$0.69 P/Share
|
|
Oct 27
2024
|
Lisa Von Moltke |
BUY
Exercise of conversion of derivative security
|
Direct |
13,744
+28.34%
|
-
|
|
Oct 27
2024
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+8.93%
|
-
|
|
Oct 27
2024
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
12,622
+13.65%
|
-
|
|
Oct 27
2024
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
11,360
+11.05%
|
-
|
|
Oct 27
2024
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
27,837
+13.8%
|
-
|